Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.165 USD | -9.34% | -7.85% | +9.93% |
09/05 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
08/05 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.93% | 468M | |
+18.53% | 47.02B | |
+48.77% | 41.86B | |
+1.39% | 41.76B | |
-4.27% | 28.8B | |
+11.32% | 26.05B | |
-21.16% | 19.15B | |
+4.69% | 12.55B | |
+27.68% | 12.34B | |
-3.57% | 11.82B |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- Morgan Stanley Adjusts Price Target on C4 Therapeutics to $8 From $1, Maintains Equal-Weight Rating